查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1815820

2025年全球脊椎生技藥品市場報告

Spine Biologics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年脊椎生技藥品市場將強勁成長，到 2029 年將達到 30.3 億美元，複合年成長率為 5.2%。預測期內的成長可歸因於技術創新、再生醫學的普及、研發投資的增加、肥胖和久坐生活方式的流行、新興市場醫療保健管道的擴大、有利的監管核准以及不斷增加的行業聯盟和夥伴關係。預測期內的主要趨勢包括新型再生療法的出現、人工智慧在治療計劃中的整合、個性化醫療方法的擴展、客製化植入的 3D 列印的應用以及用於增強組織再生的生物工程支架的開發。

未來五年5.2%的成長預測比我們先前的預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。貿易摩擦可能導致從韓國和以色列進口的去礦物質骨基質（DBM）和同種異體生技藥品的成本上升，從而導致融合手術延遲、整形外科手術費用上升，並擾亂美國脊椎外科中心的運作。互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響可能會產生更廣泛的影響。

道路交通事故發生率的上升預計將在可預見的未來推動脊椎生物製藥市場的成長。道路交通事故是指在公共道路上發生涉及一輛或多輛車輛的意外事故，導致嚴重的脊髓損傷，需要先進的醫療干預才能有效治療和康復。在全球範圍內，由於各種因素，包括分心駕駛、交通流量增加、道路基礎設施不足以及酒精和藥物影響，道路交通事故呈上升趨勢。脊椎生物製藥在改善患者預後方面發揮關鍵作用，包括促進脊椎融合、加速癒合、降低手術風險、改善疼痛管理以及最大限度地減少再次手術的需要。例如，根據美國公路交通安全管理局的數據，光是在美國，去年就有約42,915人死於機動車事故，比2020年記錄的38,824人增加了10.5%。因此，道路交通事故數量的增加正在刺激脊椎生物製藥市場的擴張。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球脊椎生技藥品：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球脊椎生技藥品市場：成長率分析
  • 全球脊椎生技藥品市場表現：規模與成長，2019-2024
  • 全球脊椎生技藥品市場預測：2024-2029年及2034年規模與成長
  • 全球脊椎生技藥品：總目標市場（TAM）

第6章 市場細分

  • 全球脊椎生技藥品市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 同種異體骨移植
  • 移植骨替代物
  • 富血小板血漿
  • 骨髓穿刺治療
  • 全球脊椎生技藥品市場（依手術類型、實際及預測），2019-2024 年、2024-2029 年、2034 年
  • 前路頸切除術切除融合術（ACDF）
  • 後路腰椎椎間融合（PLIF）
  • 椎間腰椎椎間融合（TLIF）
  • 前路腰椎椎間融合（ALIF）
  • 側腰椎椎間融合（LLIF）
  • 其他類型的手術
  • 全球脊椎生技藥品市場：依應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 脊椎融合手術
  • 脊柱不癒合和骨折修復
  • 退化性椎間盤疾病的治療
  • 其他用途
  • 全球脊椎生技藥品市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 脊椎外科中心
  • 整形外科診所
  • 其他最終用戶
  • 全球脊椎生技藥品市場：依骨同種異體移植類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 新鮮同種異體移植
  • 凍乾同種異體移植
  • 全球脊椎生技藥品市場：移植骨替代物細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 合成骨移植
  • 去礦物質骨基質（DBM）
  • 磷酸鈣植入物
  • 富血小板血漿（PRP）
  • 全球脊椎生技藥品市場：依骨髓抽吸療法細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 濃縮骨髓穿刺液
  • 骨髓濃縮物

第7章 區域和國家分析

  • 全球脊椎生技藥品市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球脊椎生技藥品市場：按國家/地區、實際和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 脊椎生技藥品市場：競爭格局
  • 脊椎生技藥品市場：公司簡介
    • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Zimmer Biomet Holdings Inc.
  • Arthrex Inc.
  • Integra LifeSciences Corporation
  • Bone Biologics Corp.
  • InVivo Therapeutics Corp.
  • RTI Surgical Inc.
  • Paragon 28 Inc.
  • LifeNet Health Inc.
  • Xtant Medical Holdings Inc.
  • Kuros Biosciences AG
  • CoreLink LLC
  • Spinal Elements Inc.
  • Life Spine Inc.
  • Innovasis Inc.
  • Camber Spine Technologies LLC

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年脊椎生技藥品市場：提供新機會的國家
  • 2029年脊椎生技藥品市場：細分領域帶來新機會
  • 2029年脊椎生技藥品市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r31289u

Spine biologics, also referred to as spinal biologics, encompass biologically derived materials employed in the treatment of spinal conditions and injuries. These materials are utilized to stimulate bone formation, accelerate healing, and enhance the outcomes of spine surgery, particularly spinal fusion procedures. They encompass a variety of products, including bone grafts, growth factors, cell-based therapies, and biological scaffolds.

The primary products within spine biologics include bone allografts, bone graft substitutes, platelet-rich plasma, and bone marrow aspirate therapy. Bone allografts are grafts sourced from donors rather than from the patient's own body. Spine biologics find application across various types of surgeries, including anterior cervical discectomy and fusion (ACDF), posterior lumbar interbody fusion (PLIF), transforaminal lumbar interbody fusion (TLIF), anterior lumbar interbody fusion (ALIF), lateral lumbar interbody fusion (LLIF), and others. These products are utilized for diverse applications such as spinal fusion, treatment of spinal non-union and fractures, management of degenerative disc disease, among others. They are employed by various end users including hospitals, spinal surgery centers, orthopedic clinics, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The spine biologics market research report is one of a series of new reports from The Business Research Company that provides spine biologics market statistics, including spine biologics industry global market size, regional shares, competitors with a spine biologics market share, detailed spine biologics market segments, market trends and opportunities, and any further data you may need to thrive in the spine biologics industry. This spine biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The spine biologics market size has grown steadily in recent years. It will grow from $2.36 billion in 2024 to $2.47 billion in 2025 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to advancements in biotechnology, an aging population, a high incidence of spinal disorders, increased preference for minimally invasive procedures, high awareness about spine health, improvements in diagnostic techniques, and enhanced healthcare infrastructure.

The spine biologics market size is expected to see strong growth in the next few years. It will grow to $3.03 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to technological innovations, increasing adoption of regenerative medicine, rising investment in R&D, growing prevalence of obesity and sedentary lifestyles, expanding healthcare access in emerging markets, favorable regulatory approvals, and increasing collaborations and partnerships within the industry. Major trends in the forecast period include emergence of novel regenerative therapies, integration of artificial intelligence in treatment planning, expansion of personalized medicine approaches, adoption of 3D printing for customized implants, and development of bioengineered scaffolds for enhanced tissue regeneration.

The forecast of 5.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. spinal surgery centers by inflating prices of demineralized bone matrix (DBM) and allograft biologics imported from South Korea and Israel, resulting in delayed fusion procedures and higher orthopedic surgery expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of road accidents is poised to drive the growth of the spinal biologics market in the foreseeable future. Road accidents, defined as unintended events involving one or more vehicles on public roads resulting in severe spinal injuries, necessitate advanced medical interventions for effective treatment and recovery. Globally, road accidents are on the rise due to various factors, including distracted driving, higher traffic volumes, inadequate road infrastructure, and impairment from alcohol and drugs. Spinal biologics play a crucial role in enhancing patient outcomes by promoting spinal fusion, accelerating healing, reducing surgical risks, improving pain management, and minimizing the need for revision operations. For example, data from the National Highway Traffic Safety Administration reveals that in the US alone, an estimated 42,915 individuals lost their lives in motor vehicle traffic crashes last year, representing a 10.5% increase from the 38,824 fatalities recorded in 2020. Hence, the escalating number of road accidents is fueling the expansion of the spinal biologics market.

Leading companies in the spinal biologics market are focusing on developing advanced products, such as synthetic bioactive bone grafts, to better cater to patient needs and maintain a competitive edge in the market. Synthetic bioactive bone grafts are artificial spine biologics engineered to support and enhance bone growth and healing in spinal fusion surgeries. For instance, Orthofix Medical Inc., a US-based spine and orthopedics company, introduced Opus BA in February 2022. Opus BA, available in putty and strip forms, serves as a scaffold for bone growth, which is reabsorbed and replaced by natural bone. It can be hydrated with autogenous bone marrow or autografted with saline and features an osteoconductive matrix comprising carbonate apatite bone mineral, bioactive glass, and Type 1 collagen, facilitating bone growth and resorption.

In August 2023, Xtant Medical, a US-based medical technology company, acquired specific assets and liabilities of domestic and international biologics and spinal fixation products from Surgalign Holdings Inc. for an undisclosed sum. This strategic acquisition is poised to bolster Xtant Medical's product portfolio and market presence in the orthopedic and spine surgery sectors, leveraging the combined capabilities of both entities. Surgalign Holdings Inc. is a US-based medical technology company specializing in spine biologics and spinal fixation products.

Major companies operating in the spine biologics market are Johnson & Johnson Services Inc., Medtronic PLC, Stryker Corporation, Baxter International Inc., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Arthrex Inc., Integra LifeSciences Corporation, Bone Biologics Corp., InVivo Therapeutics Corp., RTI Surgical Inc., Paragon 28 Inc., LifeNet Health Inc., Xtant Medical Holdings Inc., Kuros Biosciences A.G., CoreLink LLC, Spinal Elements Inc., Life Spine Inc., Innovasis Inc., Camber Spine Technologies LLC, SurGenTec LLC, ChoiceSpine LLC, Cerapedics Inc, Aziyo Biologics, Amedica Corporation

North America was the largest region in the spine biologics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spine biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the spine biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The spine biologics market consists of sales of bone morphogenetic proteins, synthetic bone grafts, and spine fusion systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Spine Biologics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on spine biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for spine biologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The spine biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Bone Allografts; Bone Graft Substitute; Platelet Rich Plasma; Bone Marrow Aspirate Therapy
  • 2) By Surgery Type: Anterior Cervical Discectomy And Fusion (ACDF); Posterior Lumbar Interbody Fusion (PLIF); Transforaminal Lumbar Interbody Fusion (TLIF); Anterior Lumbar Interbody Fusion (ALIF); Lateral Lumbar Interbody Fusion (LLIF); Other Surgery Types
  • 3) By Application: Spinal Fusion; Spinal Non-Union And Fracture Repair; Degenerative Disc Disease Treatment; Other Applications
  • 4) By End User: Hospitals; Spinal Surgery Centers; Orthopedic Clinics; Other End Users
  • Subsegments:
  • 1) By Bone Allografts: Fresh Allografts; Freeze-Dried Allografts
  • 2) By Bone Graft Substitute: Synthetic Bone Grafts; Demineralized Bone Matrix (DBM); Calcium Phosphate-Based Grafts; Platelet Rich Plasma (PRP)
  • 3) By Bone Marrow Aspirate Therapy: Concentrated Bone Marrow Aspirate; Bone Marrow Concentrates
  • Companies Mentioned: Johnson & Johnson Services Inc.; Medtronic PLC; Stryker Corporation; Baxter International Inc.; B. Braun Melsungen AG; Zimmer Biomet Holdings Inc.; Arthrex Inc.; Integra LifeSciences Corporation; Bone Biologics Corp.; InVivo Therapeutics Corp.; RTI Surgical Inc.; Paragon 28 Inc.; LifeNet Health Inc.; Xtant Medical Holdings Inc.; Kuros Biosciences A.G.; CoreLink LLC; Spinal Elements Inc.; Life Spine Inc.; Innovasis Inc.; Camber Spine Technologies LLC; SurGenTec LLC; ChoiceSpine LLC; Cerapedics Inc; Aziyo Biologics; Amedica Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Spine Biologics Market Characteristics

3. Spine Biologics Market Trends And Strategies

4. Spine Biologics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Spine Biologics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Spine Biologics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Spine Biologics Market Growth Rate Analysis
  • 5.4. Global Spine Biologics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Spine Biologics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Spine Biologics Total Addressable Market (TAM)

6. Spine Biologics Market Segmentation

  • 6.1. Global Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bone Allografts
  • Bone Graft Substitute
  • Platelet Rich Plasma
  • Bone Marrow Aspirate Therapy
  • 6.2. Global Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Anterior Cervical Discectomy And Fusion (ACDF)
  • Posterior Lumbar Interbody Fusion (PLIF)
  • Transforaminal Lumbar Interbody Fusion (TLIF)
  • Anterior Lumbar Interbody Fusion (ALIF)
  • Lateral Lumbar Interbody Fusion (LLIF)
  • Other Surgery Types
  • 6.3. Global Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spinal Fusion
  • Spinal Non-Union And Fracture Repair
  • Degenerative Disc Disease Treatment
  • Other Applications
  • 6.4. Global Spine Biologics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Spinal Surgery Centers
  • Orthopedic Clinics
  • Other End Users
  • 6.5. Global Spine Biologics Market, Sub-Segmentation Of Bone Allografts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fresh Allografts
  • Freeze-Dried Allografts
  • 6.6. Global Spine Biologics Market, Sub-Segmentation Of Bone Graft Substitute, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Synthetic Bone Grafts
  • Demineralized Bone Matrix (DBM)
  • Calcium Phosphate-Based Grafts
  • Platelet Rich Plasma (PRP)
  • 6.7. Global Spine Biologics Market, Sub-Segmentation Of Bone Marrow Aspirate Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Concentrated Bone Marrow Aspirate
  • Bone Marrow Concentrates

7. Spine Biologics Market Regional And Country Analysis

  • 7.1. Global Spine Biologics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Spine Biologics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Spine Biologics Market

  • 8.1. Asia-Pacific Spine Biologics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Spine Biologics Market

  • 9.1. China Spine Biologics Market Overview
  • 9.2. China Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Spine Biologics Market

  • 10.1. India Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Spine Biologics Market

  • 11.1. Japan Spine Biologics Market Overview
  • 11.2. Japan Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Spine Biologics Market

  • 12.1. Australia Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Spine Biologics Market

  • 13.1. Indonesia Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Spine Biologics Market

  • 14.1. South Korea Spine Biologics Market Overview
  • 14.2. South Korea Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Spine Biologics Market

  • 15.1. Western Europe Spine Biologics Market Overview
  • 15.2. Western Europe Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Spine Biologics Market

  • 16.1. UK Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Spine Biologics Market

  • 17.1. Germany Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Spine Biologics Market

  • 18.1. France Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Spine Biologics Market

  • 19.1. Italy Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Spine Biologics Market

  • 20.1. Spain Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Spine Biologics Market

  • 21.1. Eastern Europe Spine Biologics Market Overview
  • 21.2. Eastern Europe Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Spine Biologics Market

  • 22.1. Russia Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Spine Biologics Market

  • 23.1. North America Spine Biologics Market Overview
  • 23.2. North America Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Spine Biologics Market

  • 24.1. USA Spine Biologics Market Overview
  • 24.2. USA Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Spine Biologics Market

  • 25.1. Canada Spine Biologics Market Overview
  • 25.2. Canada Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Spine Biologics Market

  • 26.1. South America Spine Biologics Market Overview
  • 26.2. South America Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Spine Biologics Market

  • 27.1. Brazil Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Spine Biologics Market

  • 28.1. Middle East Spine Biologics Market Overview
  • 28.2. Middle East Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Spine Biologics Market

  • 29.1. Africa Spine Biologics Market Overview
  • 29.2. Africa Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Spine Biologics Market Competitive Landscape And Company Profiles

  • 30.1. Spine Biologics Market Competitive Landscape
  • 30.2. Spine Biologics Market Company Profiles
    • 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis

31. Spine Biologics Market Other Major And Innovative Companies

  • 31.1. Zimmer Biomet Holdings Inc.
  • 31.2. Arthrex Inc.
  • 31.3. Integra LifeSciences Corporation
  • 31.4. Bone Biologics Corp.
  • 31.5. InVivo Therapeutics Corp.
  • 31.6. RTI Surgical Inc.
  • 31.7. Paragon 28 Inc.
  • 31.8. LifeNet Health Inc.
  • 31.9. Xtant Medical Holdings Inc.
  • 31.10. Kuros Biosciences A.G.
  • 31.11. CoreLink LLC
  • 31.12. Spinal Elements Inc.
  • 31.13. Life Spine Inc.
  • 31.14. Innovasis Inc.
  • 31.15. Camber Spine Technologies LLC

32. Global Spine Biologics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Spine Biologics Market

34. Recent Developments In The Spine Biologics Market

35. Spine Biologics Market High Potential Countries, Segments and Strategies

  • 35.1 Spine Biologics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Spine Biologics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Spine Biologics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer